G. Ardine de Wit

Research interests

Publications

• Healthcare costs of patients on different renal replacement modalities – Analysis of Dutch health insurance claims data

  PLoS ONE · 2019 · https://doi.org/10.1371/journal.pone.0220800

• The impact of community-acquired pneumonia on the health-related quality-of-life in elderly

  BMC Infectious Diseases · 2017 · https://doi.org/10.1186/s12879-017-2302-3

• Impact of Survey Administration Mode on the Results of a Health-Related Discrete Choice Experiment: Online and Paper Comparison

  Value in Health · 2017 · https://doi.org/10.1016/j.jval.2017.02.007

• Dutch Tariff for the Five-Level Version of EQ-5D

  Value in Health · 2016 · https://doi.org/10.1016/j.jval.2016.01.003

• Age-specific Incidence and Prevalence of Keratoconus: A Nationwide Registration Study

  American Journal of Ophthalmology · 2016 · https://doi.org/10.1016/j.ajo.2016.12.015

• Consistency between stated and revealed preferences: a discrete choice experiment and a behavioural experiment on vaccination behaviour compared

  BMC Medical Research Methodology · 2015 · https://doi.org/10.1186/s12874-015-0010-5

• Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands

  European Respiratory Journal · 2015 · https://doi.org/10.1183/13993003.00325-2015

• The impact of a healthy lifestyle on Disability-Adjusted Life Years: a prospective cohort study

  BMC Medicine · 2015 · https://doi.org/10.1186/s12916-015-0287-6

• The Effect of Including an Opt-Out Option in Discrete Choice Experiments

  PLoS ONE · 2014 · https://doi.org/10.1371/journal.pone.0111805

• Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation

  BMJ · 2012 · https://doi.org/10.1136/bmj.e4316

• Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis

  BMJ · 2011 · https://doi.org/10.1136/bmj.d1672

• Standardizing the Inclusion of Indirect Medical Costs in Economic Evaluations

  PharmacoEconomics · 2010 · https://doi.org/10.2165/11586130-000000000-00000

• Rapid screening of methicillin-resistant Staphylococcus aureus using PCR and chromogenic agar: a prospective study to evaluate costs and effects

  Clinical Microbiology and Infection · 2010 · https://doi.org/10.1111/j.1469-0691.2010.03210.x

• Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment

  Journal of Vascular Surgery · 2010 · https://doi.org/10.1016/j.jvs.2010.04.057

• Screening and Early Treatment of Migrants for Chronic Hepatitis B Virus Infection Is Cost-Effective

  Gastroenterology · 2009 · https://doi.org/10.1053/j.gastro.2009.10.039

• Lifetime Medical Costs of Obesity: Prevention No Cure for Increasing Health Expenditure

  PLoS Medicine · 2008 · https://doi.org/10.1371/journal.pmed.0050029

• Effectiveness and Efficiency of Controlling Campylobacter on Broiler Chicken Meat

  Risk Analysis · 2007 · https://doi.org/10.1111/j.1539-6924.2007.00926.x

• The epidemiology of varicella and herpes zoster in The Netherlands: Implications for varicella zoster virus vaccination

  Vaccine · 2006 · https://doi.org/10.1016/j.vaccine.2006.02.017

• Economic Evaluation of Vaccination Programmes

  PharmacoEconomics · 2002 · https://doi.org/10.2165/00019053-200220010-00001

• Sensitivity and perspective in the valuation of health status: whose values count?

  Health Economics · 2000 · https://doi.org/10.1002/(sici)1099-1050(200003)9:2<109::aid-hec503>3.0.co;2-l

• Economic evaluation of end stage renal disease treatment

  Health Policy · 1998 · https://doi.org/10.1016/s0168-8510(98)00017-7

Current projects

No projects listed.